Theravance Biopharma (TBPH) EBITDA Margin Growth (5y) (2018 - 2026)
Theravance Biopharma (TBPH) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
50,551.00 |
| Dec 31, 2025 |
48,843.00 |
| Sep 30, 2025 |
42,253.00 |
| Jun 30, 2025 |
62,986.00 |
| Mar 31, 2025 |
542,411.00 |
| Dec 31, 2024 |
-1,965.00 |
| Sep 30, 2024 |
39,562.00 |
| Jun 30, 2024 |
-4,234.00 |
| Mar 31, 2024 |
127,699.00 |
| Dec 31, 2023 |
36,240.00 |
| Sep 30, 2023 |
40,479.00 |
| Jun 30, 2023 |
5,623.00 |
| Mar 31, 2023 |
57,243.00 |
| Dec 31, 2022 |
163,462.00 |
| Sep 30, 2022 |
892,670.00 |
| Jun 30, 2022 |
181,409.00 |
| Mar 31, 2022 |
107,759.00 |
| Dec 31, 2021 |
64,026.00 |
| Sep 30, 2021 |
-8,877.00 |
| Jun 30, 2021 |
45,631.00 |
